Hepatic fibrosis: Evaluation with semiquantitative contrast-enhanced CT

Radiology

Volumn 266, Issue 1, 2013, Pages 151-158

  Varenika, Vanja ^a   Fu, Yanjun ^a   Maher, Jacquelyn J ^a   Gao, Dongwei ^a   Kakar, Sanjay ^a   Cabarrus, Miguel C ^a   Yeh, Benjamin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED CONTRAST MEDIUM; IOHEXOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG UPTAKE; EXTRACELLULAR SPACE; FEASIBILITY STUDY; FRACTIONAL EXTRACELLULAR SPACE; HISTOPATHOLOGY; LIVER FIBROSIS; LIVER STRUCTURE; MOLECULAR WEIGHT; MORPHOMETRICS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RAT; RESPIRATORY GATED IMAGING; SCORING SYSTEM; VALIDATION PROCESS;

ALGORITHMS; ANIMALS; CONTRAST MEDIA; FEASIBILITY STUDIES; LIVER CIRRHOSIS; PATTERN RECOGNITION, AUTOMATED; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84871691850     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112452     Document Type: Article

References (39)

1. Goldin RD, Goldin JG, Burt AD, et al. Intraobserver and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996;25(5):649-654. (Pubitemid 26373881)
2. Bedossa P, Poynard T, Naveau S, Martin ED, Agostini H, Chaput JC. Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 1988;12(1):173-178. (Pubitemid 18069111)
3. Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996;43(6):568-571.
4. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1(8480):523-525. (Pubitemid 16138427)
5. Pagliaro L, Rinaldi F, Craxì A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis: a prospective, randomized trial. Dig Dis Sci 1983;28(1):39-43. (Pubitemid 13223401)
6. Seeff LB, Everson GT, Morgan TR, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010;8(10):877-883.
7. Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006;44(3):462-474. (Pubitemid 43227870)
8. Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 2006;15(2):149-159. (Pubitemid 44011767)
9. Friedrich-Rust M, Ong MF, Herrmann E, et al. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007;188(3):758-764.
10. Hotta N, Ayada M, Okumura A, et al. Noninvasive assessment of liver disease: measurement of hepatic fibrosis using tissue strain imaging. Clin Imaging 2007;31(2):87-92. (Pubitemid 46275380)
11. Rouvière O, Yin M, Dresner MA, et al. MR elastography of the liver: preliminary results. Radiology 2006;240(2):440-448. (Pubitemid 44098640)
12. Stebbing J, Farouk L, Panos G, et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 2010;44(3):214-219.
13. Dienstag JL, Goldin RD, Heathcote EJ, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003;124(1):105-117. (Pubitemid 36055344)
14. Falize L, Guillygomarc'h A, Perrin M, et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006;44(2):472-477. (Pubitemid 44214887)
15. Mallet V, Gilgenkrantz H, Serpaggi J, et al. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann Intern Med 2008;149(6):399-403.
16. Veldt BJ, Heathcote EJ, Wedemeyer H, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007;147(10):677-684. (Pubitemid 351664462)
17. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275(4):2247-2250. (Pubitemid 30081976)
18. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134(6):1655-1669. (Pubitemid 351615417)
19. Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011;364(25):2405-2416.
20. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2004;39(6):1647-1654. (Pubitemid 38702666)
21. Fowell AJ, Iredale JP. Emerging therapies for liver fibrosis. Dig Dis 2006;24(1-2):174-183.
22. Villeneuve JP, Dagenais M, Huet PM, Roy A, Lapointe R, Marleau D. The hepatic microcirculation in the isolated perfused human liver. Hepatology 1996;23(1):24-31. (Pubitemid 26012087)
23. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99(6):1160-1174. (Pubitemid 38917824)
24. Sahin S, Rowland M. Estimation of aqueous distributional spaces in the dual perfused rat liver. J Physiol 2000;528(Pt 1):199-207.
25. Reichen J. The role of the sinusoidal endothelium in liver function. News Physiol Sci 1999;14:117-121.
26. Van Beers BE, Materne R, Annet L, et al. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn Reson Med 2003;49(4):692-699. (Pubitemid 36389979)
27. Reichen J, Egger B, Ohara N, Zeltner TB, Zysset T, Zimmermann A. Determinants of hepatic function in liver cirrhosis in the rat: multivariate analysis. J Clin Invest 1988;82(6):2069-2076. (Pubitemid 19054956)
28. Whitehouse G, Worthington B. Techniques in diagnostic imaging. 3rd ed. Cambridge, Mass: Blackwell Science, 1996.
29. Shames DM, Kuwatsuru R, Vexler V, Mühler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 1993;29(5):616-622. (Pubitemid 23138050)
30. Raatschen HJ, Fu Y, Brasch RC, Pietsch H, Shames DM, Yeh BM. In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model. Invest Radiol 2009;44(5):265-270.
31. McLean EK, McLean AE, Sutton PM. Instant cirrhosis: an improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br J Exp Pathol 1969;50(5):502-506.
32. Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 1982;83(6):1183-1190. (Pubitemid 13235916)
33. Fu Y, Nitecki DE, Maltby D, et al. Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization. Bioconjug Chem 2006;17(4):1043-1056. (Pubitemid 44162625)
34. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22(6):696-699.
35. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003;38(2):481-492. (Pubitemid 36919870)
36. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999;173(2):393-398. (Pubitemid 29347365)
37. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006;239(2):425-437.
38. Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 2006;238(1):150-155. (Pubitemid 43010591)
39. Brancatelli G, Baron RL, Federle MP, Sparacia G, Pealer K. Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. AJR Am J Roentgenol 2009;192(5):1341-1347.